


Why Every Phase 1 Clinical Study Needs a “Protocol Champion”
Why Every Phase 1 Clinical Study Needs a “Protocol Champion” The clinical drug development process is challenging and time-consuming and requires the collaborative efforts of a multidisciplinary team of experts over a prolonged period of time. Accordingly, one of the...
Crossing Clinical Frontiers: My Transition from CAMH to Phase 1 Studies Manager
Crossing Clinical Frontiers: My Transition from CAMH to Phase 1 Studies Manager In a world where our beginnings often predetermine our paths, my story is a testament to the power of perseverance, adaptability, and an unyielding commitment to excellence. Born into the...
The Success Story of Repeat Business from a CRO Sponsor
The Success Story of Repeat Business from a CRO Sponsor Every successful Clinical Research Organization (CRO), whether a small startup or a large corporation, relies heavily on the support and collaboration of sponsors. These CRO sponsors serve a crucial role by...
Strategies for Successful Open-Label Clinical Trials
Strategies for Successful Open-Label Clinical Trials Designing efficient and safe clinical trials that generate reliable and accurate data is indispensable for the success of clinical drug development programs. Even though randomized, double-blind clinical trials,...
Recent Comments